American Academy of Neurology: Multiple Sclerosis risk factors and susceptibility

 

artificial-intelligence-3382507__340During the annual American Academy of Neurology meeting, researchers shared their thoughts and presented recent discoveries on risk factors and susceptibility in multiple sclerosis (MS)—a hot topic in the field. Who develops this chronic illness and why are questions that are still puzzling the research community. In general, it’s agreed that a combination of genes and environmental factors likely play a role in the development of MS.

There is an expanding list of risk factors associated with MS including those that fall in the following categories: environmental, infectious and genetic. The studies reported in this blog will focus primarily on environmental risk factors.

Continue reading

MS Society of Canada poised to feature research and researchers for May Awareness Month and World MS Day

WorldMSDay2018_CelebratingResearch_TwitterPost_ENThe theme for World MS Day (May 30) 2018 is #BringingUsCloser. The overall aim of this campaign is to bring people affected by MS closer to those involved in MS research and to create a better understanding of complex research processes. The MS Society will be jumping on this theme for MS Awareness Month as well, with a special research focus throughout the month. This theme is inclusive for people living with MS, their caregivers, friends, and family and it provides us the opportunity to talk about the MS Society’s research progress and funding.

Continue reading

American Academy of Neurology: A new biomarker to monitor disease progression and treatment response in MS

blood-1813410_960_720A major research question in multiple sclerosis (MS) is to determine if a person with MS is progressing in their disease course and how they are responding to treatments? Researchers attending the American Academy of Neurology(AAN) meeting addressed this crucial question by looking at a new emerging biomarker for MS. Biomarkers are signatures found in the body that can be objectively measured and can be an indicator of your health or reveal the presence or progress of a disease. Continue reading

70th American Academy Neurology (AAN) annual meeting: leading researchers and clinicians will gather for the largest neurology meeting of the year

AAN logoAn intense week of latest and hottest research news and updates are awaiting the research team at the 70th American Academy Neurology (AAN) annual meeting that will take place in sunny Los Angeles from April 21 to April 28. This is the largest meeting of its kind, with over 10,000 people attending including neurologist and researchers from all over the world gathering to present and discuss their recent discoveries, cutting-edge developments and advancements. This diverse meeting focuses on many areas in neurology including multiple sclerosis, dementia, epilepsy, and other neurological conditions. Educational programs are also offered to clinicians to test their knowledge and stay up to date on the best clinical practices for disease treatment and management.

Several posters and presentations from the leading MS researchers and clinicians will keep the research team buzzing around to capture and report as much information as possible. We are excited to learn about biomarkers, risk factors for MS, treatment outcomes in clinical research, and pediatric MS, just to name a few!

Want to find out about what we learn at the conference? Check out our #AAN2018 #AANAM updates next week, both here on the blog and on Twitter at @Dr_KarenLee.